Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Moderate statin treatment reduces prebeta-1 high-density lipoprotein levels in dyslipidemic patients.

Quinn AG, Schwemberger R, Stock EO, Movsesyan I, Axtell A, Chang S, Ishida BY, Malloy MJ, Kane JP, Pullinger CR.

J Clin Lipidol. 2017 Jul - Aug;11(4):908-914. doi: 10.1016/j.jacl.2017.04.118. Epub 2017 May 4.

PMID:
28558949
2.

Changing trend in referral to secondary care specialist thyroid eye disease clinic following the Amsterdam declaration.

Quinn AS, Dujardin LR, Knight B, Benzimra J, Quinn AG, Vaidya B.

Int Ophthalmol. 2018 Feb;38(1):301-306. doi: 10.1007/s10792-017-0463-0. Epub 2017 Feb 8.

PMID:
28181061
3.

Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.

Jones SA, Rojas-Caro S, Quinn AG, Friedman M, Marulkar S, Ezgu F, Zaki O, Gargus JJ, Hughes J, Plantaz D, Vara R, Eckert S, Arnoux JB, Brassier A, Le Quan Sang KH, Valayannopoulos V.

Orphanet J Rare Dis. 2017 Feb 8;12(1):25. doi: 10.1186/s13023-017-0587-3.

4.

A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.

Burton BK, Balwani M, Feillet F, Barić I, Burrow TA, Camarena Grande C, Coker M, Consuelo-Sánchez A, Deegan P, Di Rocco M, Enns GM, Erbe R, Ezgu F, Ficicioglu C, Furuya KN, Kane J, Laukaitis C, Mengel E, Neilan EG, Nightingale S, Peters H, Scarpa M, Schwab KO, Smolka V, Valayannopoulos V, Wood M, Goodman Z, Yang Y, Eckert S, Rojas-Caro S, Quinn AG.

N Engl J Med. 2015 Sep 10;373(11):1010-20. doi: 10.1056/NEJMoa1501365.

5.

Identification and metabolic profiling of patients with lysosomal acid lipase deficiency.

Pullinger CR, Stock EO, Movsesyan I, Malloy MJ, Frost PH, Tripuraneni R, Quinn AG, Ishida BY, Schaefer EJ, Asztalos BF, Kane JP.

J Clin Lipidol. 2015 Sep-Oct;9(5):716-26.e1. doi: 10.1016/j.jacl.2015.07.008. Epub 2015 Jul 26.

PMID:
26350820
6.

Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants.

Jones SA, Valayannopoulos V, Schneider E, Eckert S, Banikazemi M, Bialer M, Cederbaum S, Chan A, Dhawan A, Di Rocco M, Domm J, Enns GM, Finegold D, Gargus JJ, Guardamagna O, Hendriksz C, Mahmoud IG, Raiman J, Selim LA, Whitley CB, Zaki O, Quinn AG.

Genet Med. 2016 May;18(5):452-8. doi: 10.1038/gim.2015.108. Epub 2015 Aug 27.

7.

Clinical Features of Lysosomal Acid Lipase Deficiency.

Burton BK, Deegan PB, Enns GM, Guardamagna O, Horslen S, Hovingh GK, Lobritto SJ, Malinova V, McLin VA, Raiman J, Di Rocco M, Santra S, Sharma R, Sykut-Cegielska J, Whitley CB, Eckert S, Valayannopoulos V, Quinn AG.

J Pediatr Gastroenterol Nutr. 2015 Dec;61(6):619-25. doi: 10.1097/MPG.0000000000000935.

8.

Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency.

Valayannopoulos V, Malinova V, Honzík T, Balwani M, Breen C, Deegan PB, Enns GM, Jones SA, Kane JP, Stock EO, Tripuraneni R, Eckert S, Schneider E, Hamilton G, Middleton MS, Sirlin C, Kessler B, Bourdon C, Boyadjiev SA, Sharma R, Twelves C, Whitley CB, Quinn AG.

J Hepatol. 2014 Nov;61(5):1135-42. doi: 10.1016/j.jhep.2014.06.022. Epub 2014 Jun 30.

9.

Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.

Thelwall PE, Smith FE, Leavitt MC, Canty D, Hu W, Hollingsworth KG, Thoma C, Trenell MI, Taylor R, Rutkowski JV, Blamire AM, Quinn AG.

J Hepatol. 2013 Sep;59(3):543-9. doi: 10.1016/j.jhep.2013.04.016. Epub 2013 Apr 25.

10.

Management of patients in a combined thyroid eye clinic in secondary care.

Benzimra JD, Quinn AG, Kersey T, McGrane D, Goss L, Vaidya B.

Int Ophthalmol. 2014 Feb;34(1):1-6. doi: 10.1007/s10792-013-9768-9. Epub 2013 Apr 3.

PMID:
23549634
11.

Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease.

Balwani M, Breen C, Enns GM, Deegan PB, Honzík T, Jones S, Kane JP, Malinova V, Sharma R, Stock EO, Valayannopoulos V, Wraith JE, Burg J, Eckert S, Schneider E, Quinn AG.

Hepatology. 2013 Sep;58(3):950-7. doi: 10.1002/hep.26289. Epub 2013 Mar 28.

12.

Quality of life in thyroid eye disease: impact of quality of care.

Estcourt S, Quinn AG, Vaidya B.

Eur J Endocrinol. 2011 May;164(5):649-55. doi: 10.1530/EJE-11-0055. Epub 2011 Mar 2. Review.

PMID:
21367964
13.

National survey of the use of intraoperative antibiotics for prophylaxis against postoperative endophthalmitis following cataract surgery in the UK.

Murjaneh S, Waqar S, Hale JE, Kasmiya M, Jacob J, Quinn AG.

Br J Ophthalmol. 2010 Oct;94(10):1410-1. doi: 10.1136/bjo.2009.176883. Epub 2010 Aug 15. No abstract available.

PMID:
20710049
14.

Persistent fetal vasculature and spontaneous hyphema in a patient with Klippel-Trénaunay-Weber syndrome.

Dhir L, Quinn AG.

J AAPOS. 2010 Apr;14(2):190-2. doi: 10.1016/j.jaapos.2009.12.157.

PMID:
20451865
15.

Cataract surgery in pediatric uveitis.

Zaborowski AG, Quinn AG, Dick AD.

J Pediatr Ophthalmol Strabismus. 2008 Sep-Oct;45(5):270-8. Review.

PMID:
18825900
16.

Cataract surgery with primary intraocular lens implantation in children with chronic uveitis.

Zaborowski AG, Quinn AG, Gibbon CE, Banerjee S, Dick AD.

Arch Ophthalmol. 2008 Apr;126(4):583-4. doi: 10.1001/archopht.126.4.583. No abstract available.

PMID:
18413546
17.

Obstructive sleep apnea syndrome with bilateral papilledema and vision loss in a 3-year-old child.

Quinn AG, Gouws P, Headland S, Oades P, Pople I, Taylor D, Benton JS, Buncic JR, Henderson J, Fleming P.

J AAPOS. 2008 Apr;12(2):197-9. doi: 10.1016/j.jaapos.2007.11.015. Epub 2008 Mar 4.

PMID:
18289895
18.

Zinc therapy for night blindness in cystic fibrosis.

Tinley CG, Withers NJ, Sheldon CD, Quinn AG, Jackson AA.

J Cyst Fibros. 2008 Jul;7(4):333-5. doi: 10.1016/j.jcf.2007.11.005. Epub 2008 Jan 8.

19.

Infantile high myopia in Bohring-Opitz syndrome.

Simpson AR, Gibbon CE, Quinn AG, Turnpenny PD.

J AAPOS. 2007 Oct;11(5):524-5. Epub 2007 May 10.

PMID:
17498985
20.

Refractive outcomes after cataract surgery with primary lens implantation in infants.

Barry JS, Ewings P, Gibbon C, Quinn AG.

Br J Ophthalmol. 2006 Nov;90(11):1386-9. Epub 2006 Jul 26.

21.

Use of capsulorhexis and Healon 5 in children younger than 5 years of age.

Gibbon CE, Quinn AG.

J AAPOS. 2006 Apr;10(2):180-1. No abstract available.

PMID:
16678758
22.

A child with multiple absent extraocular muscles.

Hart J, Quinn AG, Taylor D.

J AAPOS. 2005 Feb;9(1):57-60. No abstract available.

PMID:
15729282
23.

The zinc-finger transcription factor GLI2 antagonizes contact inhibition and differentiation of human epidermal cells.

Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Ikram MS, Quinn AG, Philpott MP, Frischauf AM, Aberger F.

Oncogene. 2004 Feb 12;23(6):1263-74.

PMID:
14691458
24.

Loss of protein kinase Calpha expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma.

Neill GW, Ghali LR, Green JL, Ikram MS, Philpott MP, Quinn AG.

Cancer Res. 2003 Aug 1;63(15):4692-7.

25.

Patched, hedgehog, and skin cancer.

Quinn AG, Epstein E Jr.

Methods Mol Biol. 2003;222:85-95. Review. No abstract available.

PMID:
12710681
26.

FOXM1 is a downstream target of Gli1 in basal cell carcinomas.

Teh MT, Wong ST, Neill GW, Ghali LR, Philpott MP, Quinn AG.

Cancer Res. 2002 Aug 15;62(16):4773-80.

27.

Modulation of host antimicrobial peptide (beta-defensins 1 and 2) expression during gastritis.

Bajaj-Elliott M, Fedeli P, Smith GV, Domizio P, Maher L, Ali RS, Quinn AG, Farthing MJ.

Gut. 2002 Sep;51(3):356-61.

28.

Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma.

Regl G, Neill GW, Eichberger T, Kasper M, Ikram MS, Koller J, Hintner H, Quinn AG, Frischauf AM, Aberger F.

Oncogene. 2002 Aug 15;21(36):5529-39.

29.

Ophthalmic findings in fetal anticonvulsant syndrome(s).

Glover SJ, Quinn AG, Barter P, Hart J, Moore SJ, Dean JC, Turnpenny PD.

Ophthalmology. 2002 May;109(5):942-7.

PMID:
11986102
30.

Alveolar orbital rhabdomyosarcoma in a patient with neurofibromatosis type 1.

Glover SJ, Parkin T, Mott M, Quinn AG.

Eye (Lond). 2001 Dec;15(Pt 6):812-3. Review. No abstract available.

PMID:
11827020
31.

Tuberculous chorioretinitis.

Waheeb S, Al-Saadi M, Quinn AG, Buncic JR.

Can J Ophthalmol. 2001 Oct;36(6):344-6. No abstract available.

PMID:
11714122
32.

Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions.

Chronnell CM, Ghali LR, Ali RS, Quinn AG, Holland DB, Bull JJ, Cunliffe WJ, McKay IA, Philpott MP, Müller-Röver S.

J Invest Dermatol. 2001 Nov;117(5):1120-5.

33.

Traumatic rupture of the medial rectus muscle.

Ling R, Quinn AG.

J AAPOS. 2001 Oct;5(5):327-8.

PMID:
11641646
34.

Are keloids really "gli-loids"?: High-level expression of gli-1 oncogene in keloids.

Kim A, DiCarlo J, Cohen C, McCall C, Johnson D, McAlpine B, Quinn AG, McLaughlin ER, Arbiser JL.

J Am Acad Dermatol. 2001 Nov;45(5):707-11.

PMID:
11606920
35.

Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin.

Ali RS, Falconer A, Ikram M, Bissett CE, Cerio R, Quinn AG.

J Invest Dermatol. 2001 Jul;117(1):106-11.

36.

An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients.

Harwood CA, Swale VJ, Bataille VA, Quinn AG, Ghali L, Patel SV, Dove-Edwin I, Cerio R, McGregor JM.

J Invest Dermatol. 2001 Feb;116(2):246-53.

38.

Tumour suppressor genes.

Swale VJ, Quinn AG.

Clin Exp Dermatol. 2000 May;25(3):231-5. Review. No abstract available.

PMID:
10844504
39.

Microsatellite instability in benign skin lesions in hereditary non-polyposis colorectal cancer syndrome.

Swale VJ, Quinn AG, Wheeler JM, Beck NE, Dove-Edwin I, Thomas HJ, Bodmer WF, Bataille VA.

J Invest Dermatol. 1999 Dec;113(6):901-5.

40.

p21Wafl/Cipl and p53 expression in the skin - intertwined but not inseparable.

Quinn AG.

Br J Dermatol. 1999 Oct;141(4):614-6. No abstract available.

PMID:
10583106
41.
42.

Pediatric tetracycline-induced pseudotumor cerbri.

Quinn AG, Singer SB, Buncic JR.

J AAPOS. 1999 Feb;3(1):53-7.

PMID:
10071902
43.

Basal cell carcinoma development is associated with induction of the expression of the transcription factor Gli-1.

Green J, Leigh IM, Poulsom R, Quinn AG.

Br J Dermatol. 1998 Nov;139(5):911-5.

PMID:
9892966
44.

Ultraviolet radiation and skin carcinogenesis.

Quinn AG.

Br J Hosp Med. 1997 Sep 17-30;58(6):261-4. Review.

PMID:
9488800
45.

Expression of natural peptide antibiotics in human skin.

Fulton C, Anderson GM, Zasloff M, Bull R, Quinn AG.

Lancet. 1997 Dec 13;350(9093):1750-1. No abstract available.

PMID:
9413472
46.

Low frequency of allelic loss in skin tumours from immunosuppressed individuals.

Rehman I, Quinn AG, Takata M, Taylor AE, Rees JL.

Br J Cancer. 1997;76(6):757-9.

47.

Sebaceous hyperplasia in organ transplant recipients: shared aspects of hyperplastic and dysplastic processes?

de Berker DA, Taylor AE, Quinn AG, Simpson NB.

J Am Acad Dermatol. 1996 Nov;35(5 Pt 1):696-9.

PMID:
8912563
48.

Human homolog of patched, a candidate gene for the basal cell nevus syndrome.

Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr, Scott MP.

Science. 1996 Jun 14;272(5268):1668-71.

PMID:
8658145
49.
50.

The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo.

Norris A, Todd C, Graham A, Quinn AG, Thody AJ.

Br J Dermatol. 1996 Feb;134(2):299-306.

PMID:
8746346

Supplemental Content

Loading ...
Support Center